The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Revised U.K. guidelines for the management of cutaneous melanoma 2010: Guidelines for management of cutaneous melanoma 2010
Open accessAbstract
NHS Evidence has accredited the process used by the British Association of Dermatologists to produce guidelines. Accreditation is valid for three years from May 2010 and is applicable to guidance produced using the processes described in the British Association of Dermatologists' guidelines development manual (Bell & Ormerod, 2009). More information on accreditation can be viewed at http://www.evidence.nhs.uk.Disclaimer These guidelines reflect the best published data available at the time the report was prepared. Caution should be exercised in interpreting the data; the results of future studies may require alteration of the conclusions or recommendations in this report. It may be necessary or even desirable to depart from the guidelines in the interests of specific patients and special circumstances. Just as adherence to the guidelines may not constitute defence against a claim of negligence, so deviation from them should not necessarily be deemed negligent. These guidelines are published simultaneously in the British Journal of Dermatology (DOI 10.1111/j.1365‐2133.2010.09883.x) and the Journal of Plastic, Reconstructive & Aesthetic Surgery (DOI 10.1016/j.bjps.2010.07.006). These guidelines for the management of cutaneous melanoma present evidence‐based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiology, diagnosis, investigation and follow up. Contribution to these guidelines has been made by a large number of clinicians. They have also been endorsed by, or have had input from, representatives of the following groups or organizations: the U.K. Melanoma Study Group, the British Association of Dermatologists, the British Association of Plastic, Reconstructive and Aesthetic Surgeons, the Royal College of Physicians, London, the Association of Cancer Physicians, the Royal College of Radiologists, London, the Royal College of Surgeons of England, the Royal College of Pathologists (pathology section only), the Royal College of General Practitioners, London, and the Department of Health. These consensus guidelines have been drawn up by a multidisciplinary working party with membership drawn from a variety of groups and coordinated by the U.K. Melanoma Study Group and the British Association of Dermatologists. The guidelines deal with aspects of the management of melanoma from its prevention, through the stages of diagnosis and initial treatment to palliation of advanced disease. PubMed literature searches for this guidelines revision were carried out to identify publications from 2000 to April 2010, with search terms including: melanoma genetics, epidemiology, early diagnosis, risk factors, clinical features, pathology, surgery, chemotherapy and clinical trials. Relevant materials were also isolated from reviews and other publications identified from the PubMed searches, independent searches carried out by the authors, as well as materials collected by the authors as part of their ongoing professional interest in the latest developments in this clinical area. Levels of evidence to support the guidelines are quoted according to the criteria stated in Appendix 1. The consultation process for British Association of Dermatologists guidelines and their compliance with guideline recommendations have been published elsewhere.1, 2 There are arguments in favour of newer guideline grading methods, such as those of GRADE,3 but the authors believe that the system used here allows greater potential for consensus in areas of conflicting evidence or where evidence sources are not directly comparable. In some instances, this is not due to an absence of high quality (Level Ib) trials but because different entry criteria or endpoints preclude direct comparison of results; in other cases interpretation of the clinical significance of results has been challenged. To assist production of unified guidelines taking account of these issues, the ‘quality of evidence’ grading used in these guidelines differs slightly from that used in other British Association of Dermatologists current guidelines; the ‘strength of recommendations’ grading is the same as used in many other publications. Where no level is quoted the evidence is to be regarded as representing Level IV (i.e. a consensus statement). The intention of the working party was to agree best practice for the management of melanoma in the belief that this will promote good standards of care across the whole country. However, they are guidelines only. Care should be individualized wherever appropriate. These guidelines will be revised as necessary to reflect changes in practice in light of new evidence. Multidisciplinary care of the patient is held to be the most desirable model, as recommended in the Calman/Hine report.4 has been by the for and for with will be Cancer by Cancer Multidisciplinary will be by Cancer Multidisciplinary melanoma is a of care such that advanced
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
Morton, D. L. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420040034005 · Cited by 4,371
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
Patchell, R. A., Tibbs, P. A., Walsh, J. W., Dempsey, R. J., Maruyama, Y., Kryscio, R. J., Markesbery, W. R., Macdonald, J. S., & Young, B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002223220802 · Cited by 3,135
High Prevalence of Vitamin D Inadequacy and Implications for Health
Holick, M. F. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.3.353 · Cited by 2,005
Sentinel-Node Biopsy or Nodal Observation in Melanoma
Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Elashoff, R., Essner, R., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., Karakousis, C. P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060992 · Cited by 1,824
Middleton, M. R., Grob, J. J., Aaronson, N., Fierlbeck, G., Tilgen, W., Seiter, S., Gore, M., Aamdal, S., Cebon, J., Coates, A., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.158 · Cited by 1,272
Self-citationGandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Zanetti, R., Masini, C., Boyle, P., & Melchi, C. F. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.034 · Cited by 787
Morton, D. L., Cochran, A. J., Thompson, J. F., Elashoff, R., Essner, R., Glass, E. C., Mozzillo, N., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000181092.50141.fa · Cited by 715
Early Diagnosis of Cutaneous Melanoma: Revisiting the ABCD Criteria
Abbasi, N. R., Shaw, H. M., Rigel, D. S., Friedman, R. J., McCarthy, W. H., Osman, I., Kopf, A. W., & Polsky, D. (2004) · JAMA · doi:10.1001/jama.292.22.2771 · Cited by 668
Diagnosis and Treatment of Early Melanoma: NIH Consensus Development Panel on Early Melanoma
Goldsmith, L. A. (1992) · JAMA · doi:10.1001/jama.1992.03490100112037 · Cited by 566
Thin Stage I Primary Cutaneous Malignant Melanoma
Veronesi, U., Cascinelli, N., Adamus, J., Balch, C., Bandiera, D., Barchuk, A., Bufalino, R., Craig, P., De Marsillac, J., Durand, J. C., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181804 · Cited by 563
Self-citationThe International Agency for Research on Cancer Working Group on artificial ultraviolet (UV) light and skin cancer (2007) · International Journal of Cancer · doi:10.1002/ijc.22453 · Cited by 561
Wolfe, F., & Michaud, K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22864 · Cited by 534
Balch, C. M., Urist, M. M., Karakousis, C. P., Smith, T. J., Temple, W. J., Drzewiecki, K., Jewell, W. R., Bartolucci, A. A., Mihm, M. C., Barnhill, R., et al. (1993) · Annals of Surgery · doi:10.1097/00000658-199309000-00005 · Cited by 525
Cancer Incidence in Five Continents. Comparability and quality of data.
Dm, P., & Cs, M. (1992) · PubMed · Cited by 505
Excision Margins in High-Risk Malignant Melanoma
Thomas, J. M., Newton‐Bishop, J., A’Hern, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030681 · Cited by 504
Self-citationNarrow Excision (1-cm Margin): A Safe Procedure for Thin Cutaneous Melanoma
Veronesi, U. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410280036004 · Cited by 495
Goldstein, A. M., Chan, M., Harland, M., Gillanders, E. M., Hayward, N. K., Avril, M.-F., Azizi, E., Bianchi-Scarra, G., Bishop, D. T., Bressac-de Paillerets, B., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0494 · Cited by 426
Self-citationBalch, C. M., Soong, S.-J., Smith, T., Ross, M. I., Urist, M. M., Karakousis, C. P., Temple, W. J., Mihm, M. C., Barnhill, R. L., Jewell, W. R., et al. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0101-x · Cited by 406
Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals
Rhodes, A. R. (1987) · JAMA · doi:10.1001/jama.258.21.3146 · Cited by 330
Newton-Bishop, J. A., Beswick, S., Randerson-Moor, J., Chang, Y.-M., Affleck, P., Elliott, F., Chan, M., Leake, S., Karpavicius, B., Haynes, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1135 · Cited by 295
Self-citationIves, N. J., Stowe, R. L., Lorigan, P., & Wheatley, K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0253 · Cited by 284
Self-citationKoops, H. S., Vaglini, M., Suciu, S., Kroon, B. B., Thompson, J. F., Göhl, J., Eggermont, A. M., Di Filippo, F., Krementz, E. T., Ruiter, D., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.9.2906 · Cited by 246
Bataille, V, Bishop, J., Sasieni, P., Swerdlow, A., Pinney, E., Griffiths, K., & Cuzick, J. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.302 · Cited by 245
Epidemiology of Malignant Melanoma: Intermittent or Total Accumulated Exposure to the Sun?
ARMSTRONG, B. K. (1988) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1988.tb03588.x · Cited by 233
Surgical excision margins for primary cutaneous melanoma
Sladden, M. J., Balch, C., Barzilai, D. A., Berg, D., Freiman, A., Handiside, T., Hollis, S., Lens, M. B., & Thompson, J. F. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004835.pub2 · Cited by 226
Cornett, W. R., McCall, L. M., Petersen, R. P., Ross, M. I., Briele, H. A., Noyes, R. D., Sussman, J. J., Kraybill, W. G., Kane, J. M., Alexander, H. R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.5152 · Cited by 220
Contemporary Surgical Treatment of Advanced-Stage Melanoma
Essner, R. (2004) · Archives of Surgery · doi:10.1001/archsurg.139.9.961 · Cited by 214
Patel, P. M., Suciu, S., Mortier, L., Kruit, W. H., Robert, C., Schadendorf, D., Trefzer, U., Punt, C. J. A., Dummer, R., Davidson, N., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.030 · Cited by 211
Selection criteria for genetic assessment of patients with familial melanoma
Leachman, S. A., Carucci, J., Kohlmann, W., Banks, K. C., Asgari, M. M., Bergman, W., Bianchi-Scarrà, G., Brentnall, T., Bressac-de Paillerets, B., Bruno, W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.016 · Cited by 198
Self-citationARMSTRONG, B. K. (1984) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072002 · Cited by 194
Malignant melanoma in pregnancy: A population‐based evaluation
O'Meara, A. T., Cress, R., Xing, G., Danielsen, B., & Smith, L. H. (2005) · Cancer · doi:10.1002/cncr.20925 · Cited by 189
Effect of Pregnancy on Survival in Women With Cutaneous Malignant Melanoma
Lens, M. B., Rosdahl, I., Ahlbom, A., Farahmand, B. Y., Synnerstad, I., Boeryd, B., & Newton Bishop, J. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.096 · Cited by 180
Self-citationWagner, J. D., Schauwecker, D., Davidson, D., Coleman III, J. J., Saxman, S., Hutchins, G., Love, C., & Hayes, J. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1508 · Cited by 174
Hofmann, U., Szedlak, M., Rittgen, W., Jung, E. G., & Schadendorf, D. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600428 · Cited by 159
Wheatley, K., Ives, N. J., Eggermont, A. M. M., Kirkwood, J. M., Cascinelli, N., Markovic, S. N., Hancock, B. W., Lee, S., & Suciu, S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.8526 · Cited by 154
Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94
Mackie, R. M., Hole, D. J., Hunter, J. A. A., Rankin, R., Evans, A. T., McLaren, K. M., Fallowfield, M. E., Hutcheon, A. W., & Morris, A. (1997) · BMJ · doi:10.1136/bmj.315.7116.1117 · Cited by 153
Self-citationA systematic review of health-related quality of life in cutaneous melanoma
Cornish, D., Holterhues, C., van de Poll-Franse, L. V., Coebergh, J. W. W., & Nijsten, T. E. C. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp255 · Cited by 151
Randerson‐Moor, J. A., Taylor, J., Elliott, F., Chang, Y., Beswick, S., Kukalizch, K., Affleck, P., Leake, S., Haynes, S., Karpavicius, B., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.06.011 · Cited by 148
Self-citationMelanomas in renal transplant recipients
Mire, L. L., Hollowood, K., Gray, D. W. R., Bordea, C., & WOJNAROWSKA, F. T. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07094.x · Cited by 147
Desmoplastic Melanoma: A Pathologically and Clinically Distinct Form of Cutaneous Melanoma
Hawkins, W. G., BUSAM, K. J., Ben‐Porat, L., Panageas, K. S., Coit, D. G., Gyorki, D. E., Linehan, D. C., & Brady, M. S. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.03.022 · Cited by 147
Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma
Walling, H. W., Scupham, R. K., Bean, A. K., & Ceilley, R. I. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.02.011 · Cited by 140
Importance of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma
Wright, B. E. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.9.892 · Cited by 132
Garbe, C., Hauschild, A., Volkenandt, M., Schadendorf, D., Stolz, W., Reinhold, U., Kortmann, R., Kettelhack, C., Frerich, B., Keilholz, U., et al. (2007) · Melanoma Research · doi:10.1097/cmr.0b013e3282f05039 · Cited by 129
Does biopsy type influence survival in clinical Stage I cutaneous melanoma?
Lederman, J. S., & Sober, A. J. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70249-6 · Cited by 119
McGovern, T. W., & Litaker, M. S. (1992) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1992.tb03296.x · Cited by 116
Lees, V. C., & Briggs, J. C. (1991) · British journal of surgery · doi:10.1002/bjs.1800780923 · Cited by 104
Whiteman, D. C., & Green, A. C. (1994) · Cancer Causes & Control · doi:10.1007/bf01831385 · Cited by 99
Imiquimod in the treatment of lentigo maligna
Rajpar, S. F., & MARSDEN, J. R. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07476.x · Cited by 99
Self-citationInterobserver reproducibility of ulceration assessment in primary cutaneous melanomas
Spatz, A., Cook, M. G., Elder, D. E., Piepkorn, M. W., Ruiter, D. J., & Barnhill, R. L. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00325-3 · Cited by 97
Self-citationThe correlation of regression in primary melanoma with sentinel lymph node status
Kaur, C., Thomas, R. J., Desai, N., Green, M. A., Lovell, D., Powell, B. W. E. M., & Cook, M. G. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.049411 · Cited by 94
Self-citationInfluence of biopsy on the prognosis of cutaneous melanoma of the head and neck
Austin, J. R., Byers, R. M., Brown, W. D., & Wolf, P. (1996) · Head & Neck · doi:10.1002/(sici)1097-0347(199603/04)18:2 · Cited by 93
A pooled analysis of 10 case–control studies of melanoma and oral contraceptive use
Karagas, M. R., Stukel, T. A., Dykes, J., Miglionico, J., Greene, M. A., Carey, M., Armstrong, B. K., Elwood, M., Gallagher, R. P., Green, A. C., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600196 · Cited by 93
How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?
Newton, J. A., Bataille, V., Griffiths, K., Squire, J. M., Sasieni, P. D., Cuzick, J. M., Bishop, D. T., & Swerdlow, A. J. (1993) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(93)70279-3 · Cited by 89
Positive Iliac and Obturator Nodes in Melanoma: Survival and Prognostic Factors
Strobbe, L. J. A., Jonk, A., Hart, A. A. M., Nieweg, O. E., & Kroon, B. B. R. (1999) · Annals of Surgical Oncology · doi:10.1007/s10434-999-0255-5 · Cited by 86
Tarhini, A. A., Kirkwood, J. M., Gooding, W. E., Cai, C., & Agarwala, S. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2822 · Cited by 84
Excision Margins for Primary Cutaneous Melanoma
Lens, M. B. (2007) · Archives of Surgery · doi:10.1001/archsurg.142.9.885 · Cited by 81
Naldi, L., Altieri, A., Imberti, G. L., Giordano, L., Gallus, S., & Vecchia, C. L. (2005) · Annals of Epidemiology · doi:10.1016/j.annepidem.2004.10.005 · Cited by 78
van Rijk, M. C., Teertstra, H. J., Peterse, J. L., Nieweg, O. E., Olmos, R. A. V., Hoefnagel, C. A., & Kroon, B. B. R. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9106-9 · Cited by 77
Melanocytic Tumors of the Skin. Atlas of Tumor Pathology
Cotton, D. W. K. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.8.744-c · Cited by 73
Reproductive Risk Factors for Cutaneous Melanoma in Women: A Case-Control Study
Lea, C. S., Holly, E. A., Hartge, P. A., Lee, J. S., Guerry, D., Elder, D. E., Halpern, A. C., Sagebiel, R. W., & Tucker, M. A. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwk040 · Cited by 66
Sunburn and melanoma: how strong is the evidence?
Marks, R., & Whiteman, D. C. (1994) · BMJ · doi:10.1136/bmj.308.6921.75 · Cited by 51
Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma
Mackie, R. M., & Bray, C. A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601595 · Cited by 48
Self-citationLevodopa Therapy and the Risk of Malignant Melanoma
Siple, J. F., Schneider, D. C., Wanlass, W., & Rosenblatt, B. K. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19150 · Cited by 48
Braun, R. P., Oliviero, M., Kolm, I., French, L. E., Marghoob, A. A., & Rabinovitz, H. S. (2008) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2008.09.003 · Cited by 44
Melia, J., Cooper, E. J., FROST, T., GRAHAM-BROWN, R. A. C., Hunter, J., MARSDEN, A., du Vivier, A. W. P., White, J., Whitehead, S. M., WARIN, A. P., et al. (1995) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1995.tb08674.x · Cited by 37
How do malignant melanomas present and does this correlate with the seven-point check-list?
du Vivier, A. W. P., Williams, H. C., Brett, J., & Higgins, E. M. (1991) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1991.tb00397.x · Cited by 34
The British Association of Dermatologists guidelines for the management of skin disease
Griffiths, C. E. M. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.3029a.x · Cited by 30
Cox, N. H., Madan, V., & Sanders, T. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08519.x · Cited by 28
Self-citationChanging incidence and mortality from cutaneous malignant melanoma
Melia, J. (1997) · BMJ · doi:10.1136/bmj.315.7116.1106 · Cited by 18
Incidence, mortality and survival in cutaneous malignant melanoma in Scotland 1979???1994
MacKie, R. M., Hole, D. J., Evans, A., Rankin, R., Hunter, J. A. A., Hutcheon, A. W., & Morris, A. C. (1997) · Melanoma Research · doi:10.1097/00008390-199706001-00260 · Cited by 17
Self-citationThe British Association of Dermatologists therapeutic guidelines: can we AGREE?
Cox, N. H., & Williams, H. C. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05241.x · Cited by 17
Self-citationSöllner, W., Zschocke, I., & Augustin, M. (1998) · PubMed · Cited by 15
Cited by
Guidelines of care for the management of primary cutaneous melanoma
Swetter, S. M., Tsao, H., Bichakjian, C. K., Curiel-Lewandrowski, C., Elder, D. E., Gershenwald, J. E., Guild, V., Grant-Kels, J. M., Halpern, A. C., Johnson, T. M., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.08.055 · Cited by 727
Guidelines of care for the management of primary cutaneous melanoma
Bichakjian, C. K., Halpern, A. C., Johnson, T. M., Foote Hood, A., Grichnik, J. M., Swetter, S. M., Tsao, H., Barbosa, V. H., Chuang, T.-Y., Duvic, M., et al. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.04.031 · Cited by 616
Garbe, C., Peris, K., Hauschild, A., Saiag, P., Middleton, M., Bastholt, L., Grob, J.-J., Malvehy, J., Newton-Bishop, J., Stratigos, A. J., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.05.005 · Cited by 605
Self-citationEuropean consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022
Garbe, C., Amaral, T., Peris, K., Hauschild, A., Arenberger, P., Basset-Seguin, N., Bastholt, L., Bataille, V., del Marmol, V., Dréno, B., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.03.008 · Cited by 329
Self-citationEuropean consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022
Garbe, C., Amaral, T., Peris, K., Hauschild, A., Arenberger, P., Basset-Seguin, N., Bastholt, L., Bataille, V., del Marmol, V., Dréno, B., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.04.018 · Cited by 283
Self-citation
Metadata
- Authors
- Marsden, J. R., Newton-Bishop, J. A., Burrows, L., Cook, M., Corrie, P. G., Cox, N. H., Gore, M. E., Lorigan, P., MacKie, R., Nathan, P., Peach, H., Powell, B., & Walker, C.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-01
- Volume
- 163
- Issue
- 2
- Pages
- 238-256
- ISSN
- 0007-0963 (ISSN-L)
- OpenAlex
- W3023662983
- Cited by
- 396
- References
- 73
- FWCI
- 13.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.